Peter Pisters: Grateful to the Tanoto Foundation for its visionary support for cell therapy discovery
Peter Pisters shared on X:
“On behalf of MD Anderson Cancer Center, I am deeply grateful to the Tanoto Foundation for its visionary support for cell therapy discovery and innovation research. Breakthroughs made here have the potential to benefit humanity for generations to come.”
Read Further.
Source: Peter Pisters/X
Peter Pisters leads The University of Texas MD Anderson Cancer Center, driving research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine, and rehabilitation medicine.
He contributes to academic journals like the Journal of Clinical Oncology and Surgery, and reviews for various publications. His research, concentrated on sarcomas, GI cancers, and other malignancies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023